denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
Hematology Disease Topics & Pathways:
Biological, antibodies, therapy sequence, Diseases, Lymphoma (any), Non-Biological, Therapies, Combinations, checkpoint inhibitors, chemotherapy, enzyme inhibitors, Biological Processes, immunotherapy, epigenetics, Lymphoid Malignancies, Clinically relevant, immune mechanism
Session: Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
Hematology Disease Topics & Pathways:
Biological, antibodies, therapy sequence, Diseases, Lymphoma (any), Non-Biological, Therapies, Combinations, checkpoint inhibitors, chemotherapy, enzyme inhibitors, Biological Processes, immunotherapy, epigenetics, Lymphoid Malignancies, Clinically relevant, immune mechanism
Monday, December 7, 2020, 11:25 AM-11:30 AM
Disclosures: Amengual: Karyopharm: Consultancy; Appia Pharmaceuticals: Research Funding.
OffLabel Disclosure:
See more of: Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
See more of: Education Program
See more of: Education Program